Cardiovascular medicine prices as an indicator of access to medicines and their rational use
Aim. To perform a comparative analysis of cardiovascular medicine prices in 2011 and 2015 and to assess their availability and affordability as a basis for rational pharmacotherapy.Material and methods. We conducted a comparative analysis of prices for cardiovascular medicines in 2011 and 201 5 in K...
Saved in:
Main Authors: | C M. Razzakova (Author), L. E. Ziganshina (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Monitoring Cardiovascular Medicine Prices as a Tool for Analyzing the Effectiveness of Government Intervetions to Ensure Access to Medicines at the Regional Level
by: C. M. Razzakova, et al.
Published: (2020) -
Access and rational use of medicines in the prison system in Paraíba
by: Karla Karolline Barreto Cardins, et al.
Published: (2019) -
Medicines pricing and reimbursement: innovation, competitiveness, and access
by: Adriana M. IVAMA-BRUMMELL, et al.
Published: (2022) -
National Survey on Access, Use and Promotion of Rational Use of Medicines: methods
by: Juliana Álvares, et al.
Published: (2017) -
Indicators related to the rational use of medicines and its associated factors
by: Marina Guimarães Lima, et al.
Published: (2017)